NEWS, EVENTS, and DEADLINES

July 11, 2025

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events

Propelus I-Corps is a program designed for research teams with a technology innovation to explore how their discovery can help potential customers and meet industry needs as a startup or venture. 


Propelus I-Corps hosted by Princeton University

Photonics Theme





Sept 8, 11, 18 & Oct 2


12:30 - 3:30 pm



Virtual



Apply by Aug. 4

Find out what impact your research or innovation could have in solving real-world problems by attending the Novus I-Corps program, a half-day introduction to I-Corps.


Novus I-Corps at Princeton University






July 15


12 - 3:30 pm


Friend Center for Engineering Education

7799 William Street

Princeton



The goal of our fellowship program is to encourage students and Post-Docs to participate in an educational experience where they will explore innovation and commercialization processes while participating in an I-Corps Cohort.


We hope to expand the pipeline of future innovators through this unique program, where Fellows work alongside researchers to help understand customer needs. Selected fellows will receive a fellowship stipend.

Princeton Precision Health

2025 Seminar Series


Princeton Precision Health is a cross-cutting initiative that uses AI and data science to transform human health at all levels, from molecular to social to environmental, with the goal of enacting smart policy and evidence-based clinical practice. 

Dani S. Bassett

University of Pennsylvania


October 3

12 pm

Dan Ariely

Duke University


October 10

12 pm

252 Nassau Street

Princeton

Request for Applications

Rutgers Innovation Awards


The Rutgers Innovation Awards recognize researchers who have translated world-class research into an invention/innovation that would benefit society. 


Rutgers researchers (research faculty, research staff, postdocs, medical fellows, graduate students, undergraduate researchers) are encouraged to apply for the awards themselves and/or nominate their peers.


Deadline for application extended: July 14

Rutgers Institute for Health, Health Care Policy and Aging Research’s

Data Core

Pilot Program Request for Applications

The Data Core invites proposals for innovative pilot studies that leverage access to our database or survey resources. Up to $35,000 in funding will be granted for each awarded pilot project.

 

The key goals of this RFA are to catalyze research that leverages electronic healthcare data or survey data to address challenges in public health, health systems, patient care, and/or population health.


Deadline for submissions: July 14 by 5 pm

NJ ACTS Services

NJ ACTS Genetically informed Research, Education, And Treatment (GREAT)

The GREAT core will provide consultation on how to formulate genetically informed research and training in ethics and logistical challenges involved in genetic research to improve research plans and increase the impact of studies.


The GREAT Core supports a) the translational scientist through consultation and training on genetically-informed research, and b) the community by engaging in understanding the role of genetics in health.


The GREAT Core also provides fee-for-service in the following categories: study design, running studies, data analysis, and research training and career development.


Please complete the following Request for Consultation form and we will contact you.

 

NJ ACTS in the News

How Dad's Mental Health Can Impact Children


New research suggests that when a father experiences depression, the effects on his children can be pervasive.


The study, led by Kristine Schmitz at Rutgers Robert Wood Johnson Medical School, appeared recently in the American Journal of Preventive Medicine and was highlighted in an article in Psychology Today. Read the Full Article


Dr. Schmitz is an NJ ACTS K12 Scholar.


Rutgers News

EndNote 2025 is a program for collecting and organizing references, and the latest version for both Windows and macOS is now available for Rutgers-affiliated users to download from our citation management website.


To learn more, please visit the EndNote Tutorials Guide.

Clinical Trials Data Now Included in Embase


Elsevier has added trials data from ClinicalTrials.gov to Embase. Researchers may now view high-quality information on clinical trials and their results alongside Embase's peer-reviewed literature, in-press publications, and conference abstracts. Within Embase, each clinical trial is indexed using Emtree vocabulary and is assigned a resource type and publication type.


Researchers may continue to view clinical trials at the free site ClinicalTrials.gov. This resource integration helps Embase users find more information in one place.

 

CTSA News and Events

NCATS, NIH, and Federal News and Events

Collaboration Webinars from the

Trial Innovation Network


Hear from CTSA TIN experts on trial-related topics to improve your project

Strengthening Data Integrity in Digital Health Studies: Combating Fraud in Online Recruitment


August 4

12 - 1 pm


Register

Informed Consent Guidance Manuals and Best Practices & Strategies for Recruiting


September 17

12 - 1 pm


Register

Using Behavior, Economics and Technology to Improve Population Health Outcomes


October 15

12 - 1 pm


Register

 
NJ ACTS Publications

NJ ACTS Publication Highlights


Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries. Jennifer Miles, Peter Treitler, James Lloyd, Hillary Samples, Anais Mahone, Richard Hermida, Sumedha Gupta, Alexandra Duncan, Vanessa Baaklini, Kosali I Simon, Stephen Crystal. Health Affairs. 2023 Oct;42(10):1431-1438. doi: 10.1377/hlthaff.2023.00205.


Porous biomaterial scaffolds for skeletal muscle tissue engineering. Natalie G Kozan, Mrunmayi Joshi, Sydnee T Sicherer, Jonathan M Grasman. Frontiers in Bioengineering and Biotechnology. 2023 Oct 3:11:1245897. doi: 10.3389/fbioe.2023.1245897. eCollection 2023.

 
 

In Case You Missed It

Apply for the Translational Science Interagency Fellowship Program -NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to train fellows in translational science and regulatory science. Learn More about the Program



 

NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Components

Element B

Administration

Element C1

Workforce Development

Element C2

Community & Stakeholder Engagement

Element D1

*Biostatistics, Epidemiology &

Research Design (BERD)

*Team Science

*Regulatory Knowledge & Support

*Special Populations in Research

*Biomarkers

*Genetically informed Research

Education & Training (GREAT)

*Clinical Trials Office

Element D2

Clinical & Translational Science Pilots

Element D3

Clinical Informatics

Element E1

Clinical & Translational Science Research: Novel Genetic Services Model

Element E2

Clinical & Translational Science Research: Translating Evidence on Opioid Overdose


Additional Components

*Mentored Career Development DEVELOP (K12)

*Predoctoral Training ASCENT (T32)

*Short-Term Research CREST (R25)



Working Groups

*Health Policy in Action

*Dissemination & Implementation Science

*Team Science

*Learning Health System

*Engagement for Impact

CTSA Hub Funding Opportunities

Become a members of NJ ACTS

How to cite the CTSA Grant

 
Connect with us
Facebook  Twitter  Youtube  LinkedIn

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

 

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

 

Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved

Send story ideas to NJACTS@rbhs.rutgers.edu

 

UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)